| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 02/20/2014 | US20140051681 Mst1 kinase inhibitors and methods of their use |
| 02/20/2014 | US20140051679 Kinase inhibitors and method of treating cancer with same |
| 02/20/2014 | US20140051675 Modulators of cellular adhesion |
| 02/20/2014 | US20140051673 AMPK-Activating Heterocycloalkyloxy(Hetero)Aryl Carboxamide, Sulfonamide And Amine Compounds And Methods For Using The Same |
| 02/20/2014 | US20140051672 1,4-disubstituted pyridazine analogs there of and methods for treating smn-deficiency-related conditions |
| 02/19/2014 | EP2698368A1 Novel pyrazole derivative |
| 02/19/2014 | EP2698367A1 Benzimidazoles for the treatment of cancer |
| 02/19/2014 | EP2697218A1 Process for the preparation of compounds useful as inhibitors of sglt2 |
| 02/19/2014 | EP2697216A1 Novel compounds for organic electronic material and organic electroluminescent device using the same |
| 02/19/2014 | EP2697199A1 Aryl-or heteroaryl-substituted benzene compounds |
| 02/19/2014 | EP2697198A1 Substituted benzene compounds |
| 02/19/2014 | EP2696688A1 Use of substituted dithiine-dicarboximides for combating phytopathogenic fungi |
| 02/19/2014 | CN103596945A N-(1,2,5-oxadiazol-3-yl)-, n-(tetrazol-5-yl)- and n-(triazol-5-yl)bicycloarylcarboxamides and their use as herbicides |
| 02/19/2014 | CN103596944A Process for the preparation of compounds useful as inhibitors of SGLT2 |
| 02/19/2014 | CN103588762A Novel crystal form of canagliflozin and its preparation method |
| 02/19/2014 | CN103588718A Novel triazinedione derivatives as GABAB receptor modulators |
| 02/19/2014 | CN103588697A 2,5-disubstituted benzsulfamide compounds, preparation method thereof and applications thereof |
| 02/18/2014 | US8653270 Compounds as receptor modulators with therapeutic utility |
| 02/18/2014 | US8653259 Process for synthesizing heterocyclic compounds |
| 02/18/2014 | CA2577061C Histamine h3 receptor agents, preparation and therapeutic uses |
| 02/13/2014 | WO2014026009A2 Inhibition of antimicrobial targets with reduced potential for resistance |
| 02/13/2014 | WO2014023814A1 New antibacterial compounds |
| 02/13/2014 | WO2014023813A1 Alkylpyrimidine derivatives for the treatment of viral infections and further diseases |
| 02/13/2014 | WO2014023531A1 Trifluoromethylpyridine carboxamides as pesticides |
| 02/13/2014 | US20140045842 Method for treating an inflammatory disease by administering a 1,2,3,4-tetrahydroquinoxaline compound containing a phenyl group having a sulfonic acid ester structure introduced therein as a substituent |
| 02/13/2014 | US20140045822 Kinase inhibitors and method of treating cancer with same |
| 02/13/2014 | US20140045802 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use |
| 02/13/2014 | US20140045793 Quinolone compound and pharmaceutical composition |
| 02/12/2014 | EP2694707A1 Monomers capable of dimerizing in an aqueous solution, and methods of using same |
| 02/12/2014 | EP2694619A1 Novel organic electroluminescent compounds and an organic electroluminescent device using the same |
| 02/12/2014 | EP2694491A1 Benzodioxepine and benzodioxine compounds that interact with glucokinase regulatory protein for the treatment of diabetes |
| 02/12/2014 | EP2694479A1 Process for the preparation of an hiv integrase inhibitor |
| 02/12/2014 | EP2694476A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| 02/12/2014 | EP2694475A1 Hydroxyphenyl pyrrole compounds containing an hydroxamic acid as hdac inhibitors and medicinal applications thereof |
| 02/12/2014 | CN1980917B Novel indole derivatives as selective androgen receptor modulators (SARMS) |
| 02/12/2014 | CN103570703A Preparation and purifying method of tiagabine hydrochloride |
| 02/12/2014 | CN103570702A Method for industrial preparation of raltitrexed and novel raltitrexed crystal form for pharmacy |
| 02/12/2014 | CN103570693A Bridged compound serving as hepatitis C inhibitor and application of bridged compound in medicines |
| 02/12/2014 | CN103570653A Heterocyclic compound, organic light-emitting device including the same , and organic light-emitting display device |
| 02/12/2014 | CN103570625A N-(3-aryl-heteroaryl)-4-aryl-aryl carboxamide and analog as hedgehog pathway inhibitors and application thereof |
| 02/12/2014 | CN102093282B 肟酯光敏引发剂 Oxime ester photoinitiator |
| 02/11/2014 | US8648193 Dinitroxide-type biradical compounds optimized for dynamic nuclear polarization (DNP) |
| 02/11/2014 | CA2738563C 8-substituted isoquinoline derivatives and the use thereof |
| 02/11/2014 | CA2536622C Inhibitors of cellular necrosis |
| 02/11/2014 | CA2511199C Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 02/11/2014 | CA2501506C Modulation of anxiety through blockade of anandamide hydrolysis |
| 02/06/2014 | WO2014022728A1 Substituted 5 - (quinazolin - 2 - yl) pyrimidin- 2 -amine derivatives useful as pi3k/mtor inhibitors for the treatment of cancer |
| 02/06/2014 | WO2014022343A1 7-hydroxy-indolinyl antagonists of p2y1 receptor |
| 02/06/2014 | WO2014021281A1 Partially saturated nitrogen-containing heterocyclic compound |
| 02/06/2014 | WO2014020264A1 Novel iron complexes capable of detecting a nitro-reducing chemical or biochemical entity, in particular by in vivo mri, and in vitro detection method |
| 02/06/2014 | WO2014020105A1 Griseofulvin derivatives |
| 02/06/2014 | WO2014020101A1 Griseofulvin derivatives |
| 02/06/2014 | WO2014019951A1 Methods of controlling insects |
| 02/06/2014 | WO2013182451A9 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 02/06/2014 | US20140039195 Squarylated Lactones Inhibitors for Bacterial Biofilm Formation |
| 02/06/2014 | US20140038979 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/06/2014 | US20140038964 Imidazole based lxr modulators |
| 02/06/2014 | US20140038962 Flavivirus Inhibitors and Methods of Their Use |
| 02/06/2014 | US20140038952 Substituted Amino-Pyrimidine Derivatives |
| 02/06/2014 | US20140038936 Isoindolinone inhibitors of phosphatidylinositol 3-kinase |
| 02/06/2014 | US20140038883 Novel azacoumarin derivatives having mdr pump inhibiting activity |
| 02/05/2014 | CN103563120A Organic electronic device |
| 02/05/2014 | CN103554094A Method for preparing 2,2'-bipyridyl-4,4-(5-hexyl-2-thiophene) |
| 02/05/2014 | CN103554093A Tiagabine ethyl ester hydrochloride and preparation method thereof |
| 02/05/2014 | CN103554092A New crystal form B of 1-(beta-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl] benzene and preparation method of new crystal form B |
| 02/05/2014 | CN103554088A Benzodiazepine compound and pharmaceutical composition |
| 02/05/2014 | CN103554025A 3-pyrazole carboxylic acid amide compound and preparation method thereof as well as application of compound in preparation of medicaments as CB1 receptor inhibitors |
| 02/05/2014 | CN103554006A Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease |
| 02/04/2014 | US8642779 Compositions useful as inhibitors of protein kinases |
| 02/04/2014 | US8642774 Compounds |
| 02/04/2014 | US8642643 CXCR2 antagonists |
| 02/04/2014 | US8642642 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor |
| 02/04/2014 | US8642624 Substituted alkylamine derivatives and methods of use |
| 02/04/2014 | US8642621 (4-phenyl-piperidin-1-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanone compounds and their use |
| 02/04/2014 | US8642611 Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 02/04/2014 | US8642610 Dual small molecule inhibitors of cancer and angiogenesis |
| 02/04/2014 | US8642609 Modulators of ATP-binding cassette transporters |
| 02/04/2014 | US8642585 Indanyloxydihydrobenzofuranylacetic acids |
| 02/04/2014 | CA2645070C Pharmaceutical composition for external use |
| 02/04/2014 | CA2624450C Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/04/2014 | CA2609319C Thiophene compounds and thrombopoietin receptor activators |
| 01/30/2014 | WO2014017643A1 Difluoromethylene compound |
| 01/30/2014 | WO2014017342A1 Indole derivative or pharmacologically acceptable salt thereof |
| 01/30/2014 | WO2014017045A1 Compound having acridan ring structure, and organic electroluminescent element |
| 01/30/2014 | US20140031524 Luminescence quenching compounds |
| 01/30/2014 | US20140031394 CYCLIC SULFONIUM SALT, PROCESS FOR PRODUCTION OF SAME, AND alpha-GLUCOSIDASE INHIBITOR COMPRISING SAME |
| 01/30/2014 | US20140031350 2,4-Pyrimidinediamine Compounds and Their Uses |
| 01/30/2014 | US20140031334 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders |
| 01/30/2014 | US20140031331 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 01/30/2014 | US20140031287 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (glp-1) compound or a melanocortin-4 receptor (mic4) agonist peptide |
| 01/30/2014 | US20140030529 Chromene compound |
| 01/30/2014 | US20140030223 Inhibitors of flaviviridae viruses |
| 01/29/2014 | EP2690095A1 Aryl gpr120 receptor agonists and uses thereof |
| 01/29/2014 | EP2688403A1 Opioid receptor ligands and methods of using and making same |
| 01/29/2014 | CN1914224B HCV NS-3 serine protease inhibitors |
| 01/29/2014 | CN103547575A Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |
| 01/29/2014 | CN103539790A Rotaxane molecular machine of naphthalimide crown ether and pH meter based on rotaxane molecular machine |
| 01/29/2014 | CN103539789A Preparation method of quinazoline derivative as tyrosine kinase inhibitor |
| 01/29/2014 | CN103539751A S-triazine derivatives and application thereof to organic electroluminescence devices |
| 01/29/2014 | CN103539726A Novel compound with electron injection and/or electron transport capabilities and organic light-emitting device including the same |